CAT-13

N/A

Report date: 2025/01/26 17:42:06

Base Information

Drug NameCAT-13

Drug Alias NameAntibody-drug conjugate targeting Nectin-4 (Catalent)CAT-13

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionNectin-4 modulators

TargetsNectin-4

Therapy Area/IndicationsUrinary Bladder Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCatalent Inc

China Registration ClassN/A

Active CompaniesCatalent Inc

Inactive CompaniesN/A

Active IndicationsUrinary Bladder Neoplasms

Inactive IndicationsN/A

ATC CodeN/A